Patent US5459140A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5459140A Expired / Lapsed US ⏱️ 0.0 years remaining

Combination preparation based on dipivalylepinephrine (DPE) for reducing intraocular pressure

Assignee: Individual
•
Filing: 1993-01-19
•
Granted: 1995-10-17
•
Expires: 2013-01-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A preparation for reducing intraocular pressure consisting essentially of a therapeutically effective amount of the fixed combination of dipivalylepinephrine and carbachol (preparation 1) or dipivalylepinephrine and beta-blocker (preparation 2). The preparations may be prepared both as a solution and as a suspension. Either preparation is administered twice daily.

Inventors

  • 👤 Eugen Gramer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 23:33
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40; A61K31/21; A61K31/215; A61K31/22; A61K31/27; A61K31/335; A61K31/34; A61K31/435; A61K31/47; A61K31/535

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 25 words
Preparation for reducing intraocular pressure consisting essentially of a therapeutically effective amount of the fixed combination of dipivalylepinephrine and carbachol for those in need thereof.
Claim 2
Dependent Claim 25 words
Preparation for reducing intraocular pressure consisting essentially of a therapeutically effective amount of the fixed combination of dipivalylepinephrine and carbachol for those in need thereof.
Claim 3
Dependent Claim 19 words
Preparation in accordance with claim 1, characterized in that the dipivalyl epinephrine is present at a concentration of 0.1-0.09%.
Claim 4
Dependent Claim 18 words
Preparation in accordance with claim 2, characterized in that the carbachol is present at a concentration of 3-1.5%.
Claim 5
Dependent Claim 26 words
Preparation for reducing intraocular pressure consisting essentially of a therapeutically effective amount of the fixed combination of dipivalylepinephrine and a beta-1-beta-2-blocker for those in need thereof.
Claim 6
Dependent Claim 26 words
Preparation for reducing intraocular pressure consisting essentially of a therapeutically effective amount of the fixed combination of dipivalylepinephrine and a beta-1-beta-2-blocker for those in need thereof.

References Cited (Backward Citations)

US4904649A Cited
US4801617A Cited
US4897412A Cited
US4906467A Cited
WO1989010120A1 Cited
US5173298A Cited
US5212168A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-10-16 1999-04-17 1999-10-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-10-16 2003-04-17 2003-10-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-10-16 2007-04-17 2007-10-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag